(2-Bromo-6-chlorophenyl)methanamine

Catalog No.: 
ACBTKS634
CAS No.: 
1261471-96-8
Molecular Formula: 
C7H7BrClN
Molecular Weight: 
220.50
(2-Bromo-6-chlorophenyl)methanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$146.00InquiryInquiry
250mg97%$232.00InquiryInquiry
1g97%$610.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2-Bromo-6-chlorophenyl)methanamine
IUPAC Name(2-bromo-6-chlorophenyl)methanamine
Molecular FormulaC7H7BrClN
Molecular Weight220.50
SMILESNCC1=C(Cl)C=CC=C1Br
InChI KeyMBIMYEQDLUIZAR-UHFFFAOYSA-N
Synonym1-(2-Brom-6-chlorphenyl)methanamin;(2-Bromo-6-chlorophenyl)methanamine;2-Bromo-6-chlorobenzylamine;Benzenemethanamine, 2-bromo-6-chloro-;2-Bromo-6-chlorobenzenemethanamine
CAS No.1261471-96-8

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H314-H335
Precautionary Statement(s)
P260-P264-P270-P271-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACBTKS634 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLSRM315 route compound structure diagram
    ACLSRM3156575-08-2In Stock
  2. Then
  3. ACBTKS634 route product structure diagram
    ACBTKS6341261471-96-8
Inquiry

2. ACBTKS634 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTPCE057 route compound structure diagram
    ACTPCE05775002-98-1In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACBTKS634 route product structure diagram
    ACBTKS6341261471-96-8
Inquiry

3. ACBTKS634 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBTKS634 route product structure diagram
    ACBTKS6341261471-96-8
Inquiry

Comments (0)